| Revisiting inorganic nanoparticles as promising therapeutic agents: A paradigm shift in oncological theranostics MA Khan, D Singh, A Ahmad, HR Siddique European Journal of Pharmaceutical Sciences 164, 105892, 2021 | 39 | 2021 |
| Apigenin in cancer prevention and therapy: A systematic review and meta-analysis of animal models D Singh, M Gupta, M Sarwat, HR Siddique Critical reviews in oncology/hematology 176, 103751, 2022 | 33 | 2022 |
| Apigenin, a plant flavone playing Noble roles in Cancer prevention via modulation of key cell signaling networks D Singh, MA Khan, HR Siddique Recent Patents on Anti-Cancer Drug Discovery 14 (4), 298-311, 2019 | 33 | 2019 |
| Accentuating CircRNA-miRNA-Transcription Factors Axis: A Conundrum in Cancer Research D Singh, P Kesharwani, NA Alhakamy, HR Siddique Frontiers in pharmacology 12, 784801, 2022 | 25 | 2022 |
| Therapeutic implications of probiotics in microbiota dysbiosis: A special reference to the liver and oral cancers D Singh, MA Khan, HR Siddique Life Sciences 285, 120008, 2021 | 22 | 2021 |
| Emerging role of long non-coding RNAs in cancer chemoresistance: unravelling the multifaceted role and prospective therapeutic targeting D Singh, MA Khan, HR Siddique Molecular Biology Reports 47 (7), 5569-5585, 2020 | 21 | 2020 |
| Apigenin alleviates cancer drug Sorafenib induced multiple toxic effects in Swiss albino mice via anti-oxidative stress D Singh, MA Khan, K Akhtar, F Arjmand, HR Siddique Toxicology and Applied Pharmacology 447, 116072, 2022 | 18 | 2022 |
| Protective effect of green synthesized Selenium Nanoparticles against Doxorubicin induced multiple adverse effects in Swiss albino mice MA Khan, D Singh, A Arif, KK Sodhi, DK Singh, SN Islam, A Ahmad, ... Life Sciences 305, 120792, 2022 | 17 | 2022 |
| Role of p53-miRNAs circuitry in immune surveillance and cancer development: A potential avenue for therapeutic intervention D Singh, MA Khan, HR Siddique Seminars in Cell & Developmental Biology 124, 15-25, 2022 | 17 | 2022 |
| Antiandrogen enzalutamide induced genetic, cellular, and hepatic damages: amelioration by triterpene Lupeol MA Khan, D Singh, H Fatma, K Akhtar, F Arjmand, S Maurya, HR Siddique Drug and Chemical Toxicology 46 (2), 380-391, 2023 | 14 | 2023 |
| Specific targeting of cancer stem cells by immunotherapy: a possible stratagem to restrain cancer recurrence and metastasis D Singh, MA Khan, HR Siddique Biochemical Pharmacology 198, 114955, 2022 | 14 | 2022 |
| Role of Growth Factors in the Treatment of Diabetic Foot Ulceration D Singh, HR Siddique Diabetic Foot Ulcer: An Update, 233-249, 2021 | 13* | 2021 |
| Animal Models in Cancer Chemoprevention MA Khan, D Singh, HR Siddique International Journal of Zoology and Animal Biology 2 (5), 000171, 2019 | 9 | 2019 |
| Targeting metabolism with herbal therapy: A preventative approach toward cancer D Singh, HR Siddique Herbal Medicines, 557-578, 2022 | 8 | 2022 |
| Anti-Cancer Activity of Guggulsterone by Modulating Apoptotic Markers: A Systematic Review and Meta-Analysis M Gupta, D Singh, S Rastogi, HR Siddique, A Ahmad, M Sikander, ... Frontiers in Pharmacology 14, 1111, 2023 | 6 | 2023 |
| Role of epigenetic drugs in sensitizing cancers to anticancer therapies: emerging trends and clinical advancements D Singh, MA Khan, HR Siddique Epigenomics 15 (8), 517-537, 2023 | 6 | 2023 |
| Protective effects of a polyherbal medicine, Majoon Suranjan against bisphenol-A induced genetic, oxidative and tissue damages D Singh, MA Khan, K Akhtar, S Rehman, S Parveen, KMY Amin, ... Drug and Chemical Toxicology 46 (6), 1057-1069, 2023 | 4 | 2023 |
| PLGA-based nanoparticles for the treatment of inflammatory diseases D Singh, MA Khan, HR Siddique Poly (Lactic-Co-glycolic Acid)(PLGA) Nanoparticles for Drug Delivery, 211-233, 2023 | 4 | 2023 |
| Unveiling the therapeutic promise of natural products in alleviating drug‐induced liver injury: Present advancements and future prospects D Singh, MA Khan, HR Siddique Phytotherapy Research 38 (1), 22-41, 2023 | 3 | 2023 |
| Lupeol, an androgen receptor inhibitor, enhances the chemosensitivity of prostate cancer stem cells to antiandrogen enzalutamide-based therapy MA Khan, D Singh, M Jameel, SK Maurya, S Singh, K Akhtar, ... Toxicology and Applied Pharmacology 478, 116699, 2023 | 1 | 2023 |
Dr. Hifzur R Siddique, FBRS, MNAScAligarh Muslim UniversityVerified email at amu.ac.in
